Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease

被引：0
作者：
Clifford J. Bailey
Caroline Day
Srikanth Bellary
机构：
[1] Aston University,Life and Health Sciences
来源：
Current Diabetes Reports | 2022年 / 22卷
关键词：
Sodium-glucose co-transporter-2 (SGLT2) inhibitors; Diabetic kidney disease; Chronic kidney disease; Albuminuria; Acute kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：39 / 52
页数：13
相关论文
共 50 条
  • [1] Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
    Bailey, Clifford J.
    Day, Caroline
    Bellary, Srikanth
    CURRENT DIABETES REPORTS, 2022, 22 (01) : 39 - 52
  • [2] SGLT2 inhibitors for treatment of chronic kidney disease
    Davis, S.
    SA PHARMACEUTICAL JOURNAL, 2024, 91 (02) : 26 - 28
  • [3] Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
    Kelly, Michael S.
    Lewis, Jelena
    Huntsberry, Ashley M.
    Dea, Lauren
    Portillo, Ivan
    POSTGRADUATE MEDICINE, 2019, 131 (01) : 31 - 42
  • [4] SGLT2 Inhibitors and Diabetic Kidney Disease: Targeting Multiple and Interrelated Signaling Pathways for Renal Protection
    Papaetis, Georgios S.
    CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [5] Effects of SGLT2 Inhibitors on Renal Outcomes in Patients With Chronic Kidney Disease: A Meta-Analysis
    Li, Ning
    Lv, Dan
    Zhu, Xiangjun
    Wei, Ping
    Gui, Yuan
    Liu, Shijia
    Zhou, Enchao
    Zheng, Min
    Zhou, Dong
    Zhang, Lu
    FRONTIERS IN MEDICINE, 2021, 8
  • [6] Understanding the protective effects of SGLT2 inhibitors in type 2 diabetes patients with chronic kidney disease
    Scheen, Andre J.
    Delanaye, Pierre
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (01) : 35 - 46
  • [7] SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
    David C. Wheeler
    June James
    Dipesh Patel
    Adie Viljoen
    Amar Ali
    Marc Evans
    Kevin Fernando
    Debbie Hicks
    Nicola Milne
    Philip Newland-Jones
    John Wilding
    Diabetes Therapy, 2020, 11 : 2757 - 2774
  • [8] Mechanisms of heart failure and chronic kidney disease protection by SGLT2 inhibitors in nondiabetic conditions
    Girardi, Adriana C. C.
    Polidoro, Juliano Z.
    Castro, Paulo C.
    Pio-Abreu, Andrea
    Noronha, Irene L.
    Drager, Luciano F.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2024, 327 (03): : C525 - C544
  • [9] SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
    Wheeler, David C.
    James, June
    Patel, Dipesh
    Viljoen, Adie
    Ali, Amar
    Evans, Marc
    Fernando, Kevin
    Hicks, Debbie
    Milne, Nicola
    Newland-Jones, Philip
    Wilding, John
    DIABETES THERAPY, 2020, 11 (12) : 2757 - 2774
  • [10] SGLT2 Inhibitors to Slow Chronic Kidney Disease Progression: A Review
    Maxson, Rebecca
    Starr, Jessica
    Sewell, Jeanna
    Lyas, Claretha
    CLINICAL THERAPEUTICS, 2024, 46 (01) : e23 - e28
12345